Graft coronary artery disease in murine cardiac allografts: Proposal to meet the need for standardized assessment

Robbins, 1999, Thirty years of cardiac transplantation at Stanford University, J Thorac Cardiovasc Surg, 117, 939, 10.1016/S0022-5223(99)70375-2 Hertz, 2002, The Registry of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, 21, 950, 10.1016/S1053-2498(02)00498-9 Costanzo, 1998, Heart transplant coronary artery disease detected by coronary angiography, J Heart Lung Transplant, 17, 744 Yeung, 1995, Incidence and progression of transplant coronary artery disease over 1 year, J Heart Lung Transplant, 14, S215 Mehra, 2003, Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox, J Heart Lung Transplant, 22, 118, 10.1016/S1053-2498(02)00492-8 Kown, 2002, The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts, J Heart Lung Transplant, 21, 1009, 10.1016/S1053-2498(02)00421-7 Cantin, 2002, Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin, J Heart Lung Transplant, 21, 637, 10.1016/S1053-2498(01)00768-9 Yamaguchi, 2002, Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model, J Heart Lung Transplant, 21, 417, 10.1016/S1053-2498(01)00397-7 Lee, 2003, Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice, Transplantation, 75, 1415, 10.1097/01.TP.0000064296.65628.6C Adachi, 2002, High-level expression of viral interleukin-10 in cardiac allografts fails to prolong graft survival, Transplantation, 74, 1603, 10.1097/00007890-200212150-00019 Weetall, 2002, T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice, Transplantation, 73, 1658, 10.1097/00007890-200205270-00023 Ando, 1999, Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice, Transplantation, 68, 904, 10.1097/00007890-199909270-00026 Raisky, 2003, CD8 (+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination, J Heart Lung Transplant, 22, 177, 10.1016/S1053-2498(02)00465-5 Wang, 2002, Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions, Circulation, 105, 1609, 10.1161/01.CIR.0000013022.11250.30 Rolls, 2002, T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection, Transplantation, 74, 1053, 10.1097/00007890-200210150-00028 Furukawa, 2002, Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts, Am J Pathol, 160, 1077, 10.1016/S0002-9440(10)64928-0 Saiura, 2001, Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation, Eur J Pharmacol, 433, 163, 10.1016/S0014-2999(01)01501-1 Raisky, 2001, Acute rejection and cardiac graft vasculopathy in the absence of donor-derived ICAM-1 or P-selectin, J Heart Lung Transplant, 20, 340, 10.1016/S1053-2498(00)00192-3 Fischbein, 2001, CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model, Transplantation, 71, 1146, 10.1097/00007890-200104270-00023 Hwang, 1999, FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation, Circulation, 100, 1322, 10.1161/01.CIR.100.12.1322 Furukawa, 1999, Interleukin-10 (IL-10) augments allograft arterial disease, Am J Pathol, 155, 1929, 10.1016/S0002-9440(10)65512-5 Nagano, 1997, Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts, J Clin Invest, 100, 550, 10.1172/JCI119564 Hirozane, 1995, Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model, Circulation, 91, 386, 10.1161/01.CIR.91.2.386 Izawa, 2001, Tranilast inhibits cardiac allograft vasculopathy in association with p21 (Waf1/Cip1) expression on neointimal cells in murine cardiac transplantation model, Arterioscler Thromb Vasc Biol, 21, 1172, 10.1161/hq0701.092119 Ohki, 2001, A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB/c-to-C3H/He mouse model, J Heart Lung Transplant, 20, 956, 10.1016/S1053-2498(01)00292-3 Lee, 1999, Time-dependent expression of ICAM-1 and VCAM-1 on coronaries of the heterotopically transplanted mouse heart, J Korean Med Sci, 14, 245, 10.3346/jkms.1999.14.3.245 Ardehali, 1995, Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy, Circulation, 92, 450, 10.1161/01.CIR.92.3.450 Corry, 1973, Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection, Transplantation, 16, 343, 10.1097/00007890-197310000-00010 Aranda, 2000, Cardiac transplant vasculopathy, Chest, 118, 1792, 10.1378/chest.118.6.1792